Literature DB >> 17261732

Modeling intracerebral hemorrhage: glutamate, nuclear factor-kappa B signaling and cytokines.

Kenneth R Wagner1.   

Abstract

A significant amount of new information has been generated in animal models of intracerebral hemorrhage during the past several years. These include findings on the pathophysiological, biochemical and molecular processes that underlie the development of brain tissue injury after intracerebral hemorrhage as well as potential new treatments. We review these various findings that include glutamate receptor activation, oxidative stress development, intracellular signaling through the transcription factor, nuclear factor-kappaB, and markedly upregulated cytokine gene expression. We also briefly review the surgical treatment for intracerebral hemorrhage and list the pharmacological treatment studies that have recently appeared.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261732     DOI: 10.1161/01.STR.0000255033.02904.db

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  42 in total

1.  Oxidative-nitrosative stress in a rabbit pup model of germinal matrix hemorrhage: role of NAD(P)H oxidase.

Authors:  Muhammad T Zia; Anna Csiszar; Nazar Labinskyy; Furong Hu; Govindaiah Vinukonda; Edmund F LaGamma; Zoltan Ungvari; Praveen Ballabh
Journal:  Stroke       Date:  2009-04-16       Impact factor: 7.914

2.  Activation of acetylcholinesterase after U-74389G administration in a porcine model of intracerebral hemorrhage.

Authors:  Alexios Bimpis; Apostolos Papalois; Stylianos Tsakiris; Apostolos Zarros; Konstantinos Kalafatakis; John Botis; Vasileios Stolakis; Konstantinos M Zissis; Charis Liapi
Journal:  Metab Brain Dis       Date:  2012-04-04       Impact factor: 3.584

Review 3.  Experimental intracerebral hemorrhage: avoiding pitfalls in translational research.

Authors:  Matthew A Kirkman; Stuart M Allan; Adrian R Parry-Jones
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-24       Impact factor: 6.200

4.  Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: a postmortem study.

Authors:  He Wu; Zhiyi Zhang; Xiaoli Hu; Ruibo Zhao; Yuejia Song; Xiang Ban; Jiping Qi; Jian Wang
Journal:  Brain Res       Date:  2010-04-24       Impact factor: 3.252

5.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

6.  Poloxamer-188 can attenuate blood-brain barrier damage to exert neuroprotective effect in mice intracerebral hemorrhage model.

Authors:  Tao Wang; Xiping Chen; Zufeng Wang; Mingyang Zhang; Huanhuan Meng; Yuan Gao; Bin Luo; Luyang Tao; Yijiu Chen
Journal:  J Mol Neurosci       Date:  2014-04-29       Impact factor: 3.444

7.  Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes.

Authors:  Matthew C Loftspring; Jeremiah McDole; Aigang Lu; Joseph F Clark; Aaron J Johnson
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-01       Impact factor: 6.200

8.  Activation of TLR4-mediated NFkappaB signaling in hemorrhagic brain in rats.

Authors:  Weiyu Teng; Lishu Wang; Weishuang Xue; Chao Guan
Journal:  Mediators Inflamm       Date:  2010-01-31       Impact factor: 4.711

9.  Genomic profiles of damage and protection in human intracerebral hemorrhage.

Authors:  S Thomas Carmichael; Paul M Vespa; Jeffery L Saver; Giovanni Coppola; Daniel H Geschwind; Sidney Starkman; Chad M Miller; Chelsea S Kidwell; David S Liebeskind; Neil A Martin
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

10.  Modulation of crucial adenosinetriphosphatase activities due to U-74389G administration in a porcine model of intracerebral hemorrhage.

Authors:  Alexios Bimpis; Apostolos Papalois; Stylianos Tsakiris; Konstantinos Kalafatakis; Apostolos Zarros; Vasiliki Gkanti; Nikolina Skandali; Hussam Al-Humadi; Constantinos Kouzelis; Charis Liapi
Journal:  Metab Brain Dis       Date:  2013-01-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.